Kellner Capital’s Celator Pharmaceuticals CPXX Stock Holding History
Bought
Maintained
Sold
Kellner Capital's CPXX Position: Q3 2016 in Review
Kellner Capital sold out of Celator Pharmaceuticals (CPXX) in Q3 2016, closing a stake of 55,100 shares — an estimated $1.66M sold.
Kellner Capital first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $1.66M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.
- Kellner Capital reported no remaining Celator Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
- Kellner Capital sold 55,100 Celator Pharmaceuticals shares in Q3 2016, an estimated $1.66M.
- Kellner Capital first reported a position in Celator Pharmaceuticals in Q2 2016 and held it in 1 quarter.
- Kellner Capital's Celator Pharmaceuticals position peaked at $1.66M in Q2 2016.
- 0 funds tracked by Wall St. Rank held Celator Pharmaceuticals as of Q3 2016.
Based on Kellner Capital's 13F filing for Q3 2016, filed 9 Nov 2016.